new tirzepatide is a Medication for Diabetes and Weight Loss Mounjaro and Zepbound Are No

PlexusDx explains potential interactions, absorption concerns, and how to safely use both medications together

Industry forecasts suggest that the Indian GLP-1 market could reach nearly USD 350 million (~2,900 crore) by 2030, growing at an estimated ~25% CAGR

Kentucky residents have three paths to GLP-1 weight-loss therapy in 2026: brand-name FDA-approved medication (Wegovy, Zepbound) at retail or Lilly Direct, in-person clinical care through systems like UK HealthCare Turfland, and cash-pay compounded telehealth

Mounjaro is a prescription injection approved for type 2 diabetes that helps lower blood sugar, improve insulin sensitivity, and support weight loss

Yerba Mat, a traditional South American herbal infusion abundant in bioactive compounds, has been suggested to offer health benefits including lipid regulation and weight management